wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42370483-0910CCED-4F53-4795-8E9B-DDB5F3E48B48
Q42370483-0910CCED-4F53-4795-8E9B-DDB5F3E48B48
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42370483-0910CCED-4F53-4795-8E9B-DDB5F3E48B48
Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus.
P2860
Q42370483-0910CCED-4F53-4795-8E9B-DDB5F3E48B48
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42370483-0910CCED-4F53-4795-8E9B-DDB5F3E48B48
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e8560ef6848275965dbedd10a84679d16fa304a2
P2860
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial.